10-Q · May 15, 2026
NeOnc Technologies Holdings, Inc. reported zero revenue for Q4 2025, continuing the trend of significant operational challenges. The net loss for the quarter was $8,819,932, an improvement from a loss of $32,326,016 in…
Earnings analysis · 10-Q
NTHI earnings analysis
Filed August 10, 2026 · Our reading of the company's report
The latest report
The supplied filing extract does not include the Q2 income statement, balance sheet, or cash-flow statement, so revenue, margins, EPS, cash, debt, working capital, and free cash flow cannot be quantified. The company…
Read full summary
The supplied filing extract does not include the Q2 income statement, balance sheet, or cash-flow statement, so revenue, margins, EPS, cash, debt, working capital, and free cash flow cannot be quantified. The company raised $7.0 million in equity capital and eliminated a $737,921 Fox Infused settlement, but still reported ineffective disclosure controls and an unpaid OEP settlement payable of $4,378,904. No quantitative guidance was provided, and the filing states that the material risk factors were unchanged from the prior Form 10-K.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
What stood out
-
Raised $7.0M in Equity Capital
The company raised $7.0 million during the quarter: $2.0 million from an April common-stock and warrant private placement and $5.0 million from June issuance of 6,000 Series A Convertible Preferred shares.
-
Cleared Fox Infused Obligation
NeOnc paid the Fox Infused settlement in full in February 2026, including accrued interest, for a total payment of $737,921; no related liability remained as of June 30, 2026.
-
Expanded Control-Remediation Program
Management initiated remediation measures including a new NetSuite ERP implementation, an information-technology controls consultant, a formal related-party transaction policy, and hiring a Chief Accounting Officer.
What to watch
-
Material Internal-Control Weaknesses Persist
Management concluded that disclosure controls were not effective as of June 30, 2026 because of material weaknesses spanning segregation of duties, entity-level controls, significant transaction classes, related-party transaction controls, and information-technology user access.
-
$4.38M Unpaid OEP Settlement
The OEP litigation settlement payable increased to $4,378,904 at June 30, 2026 from $4,170,000 at December 31, 2025, and the company had not paid the settlement as of the filing date.
-
Equity Dilution and Insider Selling Risk
The April financing issued 277,777 common shares and warrants for 277,777 additional shares at a $9.00 exercise price, while directors and officers adopted trading plans covering up to 190,000 shares in June 2026, creating potential dilution and selling pressure.
Management's outlook
No quantitative revenue or EPS outlook was provided in the filing. The filing states that no material risk-factor changes occurred versus the December 31, 2025 Form 10-K.
Earlier filings 2
10-K · May 5, 2026
NeOnc Technologies Holdings, Inc. reported significant operating challenges in 2025, highlighted by zero revenue in Q4 and a diluted EPS loss of -0.72. The company is focused on preclinical trials and aims to address…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.